Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case-control study

Keyphrases

• Ovarian Cancer 100%
• Serum 25-hydroxyvitamin D 100%
• Ovarian Cancer Risk 100%
• Prospective Case-control Study 100%
• Joint Effect 100%
• Confidence Interval 50%
• Odds Ratio 50%
• 25-hydroxyvitamin D (25OHD) 50%
• Vitamin D 50%
• Serum Calcium 33%
• Decreased Risk 33%
• Prediagnostic Serum 33%
• Statistical Significance 16%
• Relative Risk 16%
• Modifiable Risk Factors 16%
• Inverse Association 16%
• Serum 25OHD 16%
• Ovarian Cancer Screening 16%
• Cancer Cases 16%
• Nested Case-control Study 16%
• Population-based 16%
• Cancer-related 16%
• Blood Donation 16%
• Late Development 16%
• Serum Vitamin 16%
• Serum 25(OH)D Levels 16%
• Maternity 16%
• Cohort Subset 16%
• Dietary Studies 16%

Medicine and Dentistry

• Isotopes of Calcium 100%
• Cancer Risk 100%
• Ovarian Cancer 100%
• 25 Hydroxyvitamin D 100%
• Case-Control Study 100%
• Vitamin D 27%
• Odds Ratio 27%
• Diagnosis 18%
• Obstetrics 9%
• Blood Donor 9%
• Ovarian Cancer Prevention 9%

Pharmacology, Toxicology and Pharmaceutical Science

• 25 Hydroxyvitamin D 100%
• Ovary Cancer 100%
• Case-Control Study 100%
• Vitamin D 25%